Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 1.00 |
| ▸ | CA9 | Q16790 | 8/20 | 1.00 |
| ▸ | CA1 | P00915 | 5/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | GLA | P06280 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | IL2 | P60568 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.56 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.56 |
| ▸ | ALDH1B1 | P30837 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL260974 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL10048269 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL15484273 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL755988 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL1526661 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL15745917 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL2319034 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL165912 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL152641 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 | |
| SCHEMBL1356276 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602369-A1 | ASSAYS FOR LYSOSOMAL STORAGE DISEASES | Sangamo Therapeutics, Inc. (US) | 2025-08-20 | — | — | EP | claimed |
| WO-2024081868-A9 | ASSAYS FOR LYSOSOMAL STORAGE DISEASES | SANGAMO THERAPEUTICS, INC. (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2024081868-A1 | ASSAYS FOR LYSOSOMAL STORAGE DISEASES | SANGAMO THERAPEUTICS, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| EP-3749775-B1 | IMPROVED METHOD FOR MEASUREMENT OF MICROBIAL BIOMASS | MYCOMETER AS (DK) | 2023-06-07 | — | — | EP | claimed |
| EP-3845249-A1 | TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF | Chengdu Ribocure Pharmatech Company Limited (CN) | 2021-07-07 | — | — | EP | claimed |
| US-20210196832-A1 | TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF | CHENGDU RIBOCURE PHARMATECH COMPANY LIMITED (CN) | 2021-07-01 | — | — | US | claimed |
| US-20210115494-A1 | Improved method for measurement of microbial biomass | MYCOMETER A/S (DK) | 2021-04-22 | — | — | US | claimed |
| EP-3749775-A1 | IMPROVED METHOD FOR MEASUREMENT OF MICROBIAL BIOMASS | Mycometer A/S (DK) | 2020-12-16 | — | — | EP | claimed |
| CN-111699265-A | Improved method for measuring microbial biomass | 麦卡米特有限公司 | 2020-09-22 | — | — | CN | claimed |
| WO-2019154898-A1 | IMPROVED METHOD FOR MEASUREMENT OF MICROBIAL BIOMASS | MYCOMETER A/S (DK) | 2019-08-15 | — | — | WO | claimed |
| WO-2008082728-A2 | STERILIZATION INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-10 | — | — | WO | claimed |
| WO-2008079469-A2 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| US-20080070231-A1 | Reporter genes taken up by microorganism, and repressor gene inhibits expression | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-20080070272-A1 | STERILIZATION INDICATOR | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-20040166554-A1 | Method for assaying the activity of lysosomal enzymes | LYSOMETRIX CORP. | 2004-08-26 | — | — | US | claimed |
| US-6764832-B2 | COMPOSITION FOR USE IN THE DETECTION OF SHIGELLA IN SAMPLE | R&F PRODUCTS, INC. | 2004-07-20 | — | — | US | claimed |
| US-20030049718-A1 | Plating media for the presumptive identification of the genus Shigella and the species Shigella sonnei and shigella boydii | R&F PRODUCTS, INC. | 2003-03-13 | — | — | US | claimed |
| WO-2002018539-A2 | METHOD FOR ASSAYING THE ACTIVITY OF LYSOSOMAL ENZYMES | LYSOMETRIX CORPORATION (US) | 2002-03-07 | — | — | WO | claimed |
| US-5094944-A | Umbelliferyl containing substrates | HAYES KENNETH R (US) | 1992-03-10 | — | — | US | claimed |
| WO-1990012886-A1 | FLUORESCENT AQUATIC BIOASSAY AND PROCEDURE | HAYES KENNETH R (US) | 1990-11-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210196832-A1 | TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF | M6PR, IGF2R, MAN2A1 | CA12 2927/4885CA9 2847/4885CA1 3599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.